On Monday, April 1, we announced our plans to acquire Chemistry Holdings, a formulation technology company that is developing innovative delivery systems for the nutraceutical and pharmaceutical industry. An Expansion of Our Platform With this acquisition, we...
The 2018 Farm Bill, which was passed by Congress and signed by President Donald Trump today, is a large, multifaceted piece of legislation outlining regulations on everything from food stamps to environmental land use. Renewed roughly every five years, the farm bill...
CURE Pharma open to US CRO contract in February 2019 for PK/bioavailability study for thin film sildenafil, updates NASDAQ up-listing and partnering plans, CEO says CURE Pharmaceuticals (OTC:CURR) welcomes CRO approaches in February 2019 for a...
In this third and final installment of our blog series on cannabinoids, we examine the current legal status of cannabis and products derived from the plant. Click to read the other articles in this series: The Role of the Endocannabinoid System in the Human Body and...
Our partner, Sleep Club just launched a new product, Sleep StripZZZ- an innovative sleep and recovery aid powered by our CUREfilm technology. It contains a soothing blend of melatonin, naturally occurring amino acids and beneficial vitamins that promote balanced sleep...
Our COO Jessica Rousset did a quick interview with Proactive Investors last week. She discussed the CURE Pharmaceutical licensing deal with Canopy Growth Corp where Canopy will have an exclusive license to our patented, multi-layer oral thin film technology for use...
